Prognostic implication of DPD quantification in transthyretin cardiac amyloidosis
In ATTR-CA, enhanced quantitative LV DPD uptake indicates advanced disease severity and is associated with adverse outcome. DPD quantification may facilitate prognostic stratification when diagnosing patients with ATTR-CA.
Authors
- Christian Hengstenberg (ORCID: https://orcid.org/0000-0002-8284-2994)
- Christina Binder
- Felix Hofer (ORCID: https://orcid.org/0000-0002-0185-7511)
- Nikita Ermolaev (ORCID: https://orcid.org/0000-0003-4317-9277)
- Roza Badr Eslam (ORCID: https://orcid.org/0000-0002-0360-2360)
- Robin Willixhofer (ORCID: https://orcid.org/0000-0003-3405-5715)
- Christian Nitsche (ORCID: https://orcid.org/0000-0002-0141-7639)
- Marcus Hacker (ORCID: https://orcid.org/0000-0002-4222-4083)
- Johannes Kästner (ORCID: https://orcid.org/0000-0001-6178-7669)
- Franz Duca (ORCID: https://orcid.org/0000-0002-7519-5274)
- Michael Poledniczek (ORCID: https://orcid.org/0000-0002-6091-9823)
- Jutta K Bergler-Klein (ORCID: https://orcid.org/0000-0003-2591-1380)
- Christina Kronberger (ORCID: https://orcid.org/0000-0002-3866-3710)
- René Rettl (ORCID: https://orcid.org/0000-0001-6409-5158)
- Andreas Anselm Kammerlander (ORCID: https://orcid.org/0000-0002-7632-9879)
Institutions
- Medical University of Vienna (AT)
Publication Details
- Journal
- European Heart Journal - Cardiovascular Imaging
- Published
- 2024-11-15
- DOI
- https://doi.org/10.1093/ehjci/jeae295
- Citations
- 10
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.34